Pharmacology, Physiology, and Drug Development


Thursday, February 01, 2024

Margaret 'Peg' McCarthy, PhD, interviewed by Jon Hamilton on "All Things Considered," National Public Radio – October 5, 2023

New Research Shows How Brain Inflammation in Children May Cause Neurological Disorders Such as Autism or Schizophrenia


Monday, January 01, 2024

Katie Kruk, BS, Received Three-Year F30 Grant from the National Heart, Lung, and Blood Institute (NHLBI)

Katie Kruk, BS, received a three-year F30 grant from the National Heart, Lung, and Blood Institute (NHLBI) for “A Role for the Orphan Receptor, GPR37, in Estradiol-induced Changes in Sleep-Wake States.”


Tuesday, December 12, 2023

Min Yu, PhD Published in Advanced Science

Ectopic expression of a truncated isoform of hair keratin 81 in breast cancer alters biophysical characteristics to promote metastatic propensity.


Thursday, November 30, 2023

Brian Herb, PhD, and Seth Ament, PhD, Published in Science Advances

First author Brian Herb, PhD, Research Associate, Department of Pharmacology, and last author Seth Ament, PhD, Associate Professor, Department of Psychiatry, who are both members of IGS, published the article "Single-cell genomics reveals region-specific developmental trajectories underlying neuronal diversity in the human hypothalamus."


Wednesday, November 22, 2023

Alexandros Poulopoulos, PhD, Elected to MECQI for a Two-Year Term

Alexandros Poulopoulos, PhD, Assistant Professor, Dept. of Pharmacology & UM-MIND, was elected to MECQI for a two-year term.


Wednesday, November 15, 2023

Alexandros Poulopoulos, PhD, Published as the Cover Article of the CRISPR Journal

Alexandros Poulopoulos, PhD, Assistant Professor, Department of Pharmacology & UM-MIND, was the last author of "Enhancing Precision and Efficiency of Cas9-Mediated Knockin Through Combinatorial Fusions of DNA Repair Proteins," which was published as the cover article of the October 2023 issue of the CRISPR Journal.


Saturday, November 11, 2023

Anna Maximova, BS, Received Two-Year F30 Training Grant

Anna Maximova, BS, received a two-year F30 training grant from the National Institute of Mental Health (NIH/NIMH) for "A unique peri-hippocampal mast cell population drives neurodevelopment."